Application of method suitability for drug permeability classification.
Experimental models of permeability in animals, excised tissues, cell monolayers, and artificial membranes are important during drug discovery and development as permeability is one of several factors affecting the intestinal absorption of oral drug products. The utility of these models is demonstrated by their ability to predict a drug's in vivo intestinal absorption. Within the various permeability models, there are differences in the performance of the assays, along with variability in animal species, tissue sources, and cell types, resulting in a variety of experimental permeability values for the same drug among laboratories. This has led to a need for assay standardization within laboratories to ensure applicability in the drug development process. Method suitability provides a generalized approach to standardize and validate a permeability model within a laboratory. First, assay methodology is optimized and validated for its various experimental parameters along with acceptance criteria for the assay. Second, the suitability of the model is demonstrated by a rank order relationship between experimental permeability values and human extent of absorption of known model compounds. Lastly, standard compounds are employed to classify a test drug's intestinal permeability and ensure assay reproducibility and quality. This review will provide examples of the different aspects method suitability for in situ (intestinal perfusions), ex vivo (everted intestinal sacs, diffusion chambers), and in vitro (cell monolayers, artificial membranes) experimental permeability models. Through assay standardization, reference standards, and acceptance criteria, method suitability assures the dependability of experimental data to predict a drug's intestinal permeability during discovery, development, and regulatory application.
Volpe
Donna A
DA
Center for Drug Evaluation and Research, Silver Spring, Maryland 20993-0002, USA. donna.volpe@fda.hhs.gov
D000818:Animals; D006801:Humans; D008962:Models, Theoretical; D010539:Permeability; D010599:Pharmacokinetics
Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5
1673839
Eur J Pharm Sci. 2005 Jun;25(2-3):193-200
15911214
Gastroenterology. 1989 Mar;96(3):736-49
2914637
Med Res Rev. 1995 Mar;15(2):83-109
7537838
Pharm Res. 2003 Dec;20(12):1961-9
14725360
J Pharm Belg. 2002 Nov-Dec;57(6):153-8
12596572
Mol Pharm. 2006 Nov-Dec;3(6):686-94
17140256
J Pharm Sci. 2004 Dec;93(12):2909-19
15459890
Mol Pharm. 2009 Jan-Feb;6(1):11-8
19248229
J Pharm Sci. 1998 Mar;87(3):360-6
9523990
Curr Top Med Chem. 2001 Nov;1(5):367-83
11899103
J Pharm Sci. 1969 Oct;58(10):1196-200
5394662
J Pharm Sci. 1999 Jan;88(1):28-33
9874698
J Med Chem. 2005 Jan 27;48(2):604-13
15658873
Eur J Med Chem. 2006 May;41(5):605-10
16546303
J Pharmacol Exp Ther. 1958 May;123(1):81-8
13539795
Eur J Pharm Sci. 2006 Mar;27(4):346-53
16359848
Eur J Pharm Sci. 2006 Mar;27(4):354-62
16364612
Eur J Pharm Sci. 2004 Mar;21(4):553-60
14998587
ALTEX. 2004;21 Suppl 3:57-64
15057409
Int J Clin Pharmacol Ther. 1998 Feb;36(2):86-9
9520153
J Pharm Sci. 2008 Feb;97(2):712-25
17542022
Eur J Pharm Sci. 2006 Apr;27(5):543-54
16406207
Pharm Res. 1998 Sep;15(9):1490-4
9755906
J Med Chem. 2001 Mar 15;44(6):923-30
11300874
Pharm Res. 1997 Dec;14(12):1792-7
9453070
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):27-43
11259831
Drug Dev Ind Pharm. 2009 Dec;35(12):1496-502
19929209
Scand J Gastroenterol. 2000 May;35(5):501-7
10868453
J Pharmacol Exp Ther. 2002 Dec;303(3):889-95
12438506
Eur J Pharm Biopharm. 2006 Nov;64(3):369-78
16905298
J Pharm Pharmacol. 1997 Jul;49(7):627-38
9255703
Int J Pharm. 2000 Apr 25;200(1):41-51
10845684
Eur J Pharm Sci. 2006 Jan;27(1):80-90
16246536
Adv Drug Deliv Rev. 2002 Mar 31;54(3):273-89
11922948
Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S51-60
11033427
Pharm Res. 1991 Aug;8(8):979-88
1924168
Pharm Res. 1997 Dec;14(12):1655-8
9453050
AAPS PharmSci. 2004 Apr 05;6(2):e13
15760043
J Med Chem. 1998 Mar 26;41(7):1007-10
9544199
J Pharm Pharmacol. 1997 Jul;49(7):687-90
9255712
Pharm Res. 1996 Sep;13(9):1336-42
8893271
Curr Top Med Chem. 2001 Nov;1(5):385-401
11899104